The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

2009 • 1,580 citations

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

2007 • 630 citations

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

2009 • 626 citations

Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials

2007 • 581 citations

Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident Infection

2000 • 561 citations

Immune responses to human papillomavirus

2005 • 559 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.

2001 • 481 citations

Health and Economic Implications of HPV Vaccination in the United States

2008 • 362 citations

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

2003 • 333 citations

Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer

2002 • 314 citations

Trends of cervical cancer mortality in the member states of the European Union

2009 • 304 citations

Economic evaluation of human papillomavirus vaccination in the United Kingdom

2008 • 279 citations

The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years

2009 • 228 citations

Race and Colorectal Cancer Disparities: Health-Care Utilization vs Different Cancer Susceptibilities

2010 • 210 citations

Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women

2004 • 194 citations

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials

2007 • 193 citations

High-risk HPV type-specific clearance rates in cervical screening

2007 • 161 citations

Cost-Effectiveness of Cervical Cancer Screening: Comparison of Screening Policies

2002 • 119 citations

Monitoring a national cancer prevention program: Successful changes in cervical cancer screening in the netherlands

2006 • 107 citations

The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey

2010 • 103 citations

Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening

2008 • 97 citations

Mass screening programmes and trends in cervical cancer in Finland and the Netherlands

2007 • 91 citations

Eurogin 2010 roadmap on cervical cancer prevention

2011 • 87 citations

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

2007 • 86 citations

The epidemiological and economic impact of a quadrivalent human papillomavirus vaccine (6/11/16/18) in the UK

2008 • 86 citations

Model-Based Estimation of Viral Transmissibility and Infection-Induced Resistance From the Age-Dependent Prevalence of Infection for 14 High-Risk Types of Human Papillomavirus

2010 • 77 citations

Cost-Effectiveness Analysis of Human Papillomavirus Vaccination in the Netherlands

2009 • 74 citations

Long-term Impact of Human Papillomavirus Vaccination on Infection Rates, Cervical Abnormalities, and Cancer Incidence

2011 • 66 citations

Incidence and survival rate of women with cervical cancer in the Greater Amsterdam area

2003 • 62 citations

Trends in cervical cancer in the Netherlands until 2007: Has the bottom been reached?

2010 • 56 citations

Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis

2005 • 51 citations

Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands

2007 • 49 citations

HPV16/18 vaccination to prevent cervical cancer in The Netherlands: Model‐based cost‐effectiveness

2008 • 39 citations

Age-Based Programs for Vaccination against HPV

2009 • 31 citations

Implementation of the Australian HPV vaccination program for adult women: Qualitative key informant interviews

2009 • 24 citations

Measurement of the Humoral Immune Response following an Incident Human Papillomavirus Type 16 or 18 Infection in Young Women by a Pseudovirion-Based Neutralizing Antibody Assay

2008 • 14 citations

Deleted Work

1955 • 0 citations